Geranylgeraniol promotes osteoblast differentiation and inhibits osteoclastogenesis through MAPK and nuclear receptor signaling
Open Access
- 6 May 2026
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (6) , 113108
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science (JP16K11487andJP19K10060)
- University of Tokushima
This publication has 63 references indexed in Scilit:
- Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic reviewJournal of Bone and Mineral Metabolism, 2022
- Link between microbiota and hypertension: Focus on LPS/TLR4 pathway in endothelial dysfunction and vascular inflammation, and therapeutic implication of probioticsBiomedicine & Pharmacotherapy, 2021
- c-Jun N-Terminal Kinases (JNKs) Are Critical Mediators of Osteoblast Activity In VivoJournal of Bone and Mineral Research, 2017
- The potential of the mevalonate pathway for enhanced isoprenoid productionBiotechnology Advances, 2016
- Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis FoundationOsteoporosis International, 2015
- Positive regulation of osteogenesis by bile acid through FXRJournal of Bone and Mineral Research, 2013
- Dietary supplementation with geranylgeraniol suppresses lipopolysaccharide-induced inflammation via inhibition of nuclear factor-κB activation in ratsEuropean Journal of Nutrition, 2012
- Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone lossJournal of Bone and Mineral Research, 2012
- Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblastsBone, 2011
- The role of alkaline phosphatase in cartilage mineralizationBone and Mineral, 1992